Cell Care Therapeutics

Cell Care Therapeutics

Biotechnology, 750 Royal Oaks Dr, Monrovia, California, 90814, United States, 1-10 Employees

cell-care.com

  • facebook
  • LinkedIn

phone no Phone Number: 56********

Who is CELL CARE THERAPEUTICS

Cell Care Therapeutics is developing a new class of biologics that are derived from the secreted proteins and exosomes of mesenchymal stromal cells (MSCs). The companys novel secretome pl...

Read More

map
  • 750 Royal Oaks Dr, Monrovia, California, 90814, United States Headquarters: 750 Royal Oaks Dr, Monrovia, California, 90814, United States
  • 2014 Date Founded: 2014
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2833

checked-icon Does something look wrong? Fix it. | View contact records from CELL CARE THERAPEUTICS

Cell Care Therapeutics Org Chart and Mapping

Employees

Veronique Jotterand

Chief Medical Officer ; Pediatric Ophthalmologist

Emilie Sohl

Business Development Intern

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cell Care Therapeutics

Answer: Cell Care Therapeutics's headquarters are located at 750 Royal Oaks Dr, Monrovia, California, 90814, United States

Answer: Cell Care Therapeutics's phone number is 56********

Answer: Cell Care Therapeutics's official website is https://cell-care.com

Answer: Cell Care Therapeutics's revenue is $1 Million to $5 Million

Answer: Cell Care Therapeutics's SIC: 2833

Answer: Cell Care Therapeutics has 1-10 employees

Answer: Cell Care Therapeutics is in Biotechnology

Answer: Cell Care Therapeutics contact info: Phone number: 56******** Website: https://cell-care.com

Answer: Cell Care Therapeutics is developing a new class of biologics that are derived from the secreted proteins and exosomes of mesenchymal stromal cells (MSCs). The companys novel secretome platform harnesses the signaling molecules of MSCs to promote the health of blood vessels and their surrounding tissue. The company is developing its first product for the treatment of diabetic macular edema, the leading cause of vision loss in working age adults.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access